Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for technology industry professionals · Thursday, March 28, 2024 · 699,488,254 Articles · 3+ Million Readers

The Global Market for Interventional Radiology: 2014-2018 Analysis & 2019-2024 Forecasts

Dublin, March 26, 2019 (GLOBE NEWSWIRE) -- The "Interventional Radiology Market (2014-2024)" report has been added to ResearchAndMarkets.com's offering.

According to this study, the interventional radiology market is expected to reach $27.3 billion in terms of revenue generation by 2024, witnessing a CAGR of 6.4% during the forecast period.

The key factors driving the market are increasing prevalence of chronic diseases, advancements in technology, growing aging population, and improving reimbursement rate for interventional radiology procedures.

There are different types of products available in the interventional radiology market, including magnetic resonance imaging (MRI), ultrasound, computed tomography (CT), angiography systems, and others. The market for ultrasound systems is estimated to progress substantially during the forecast period, registering a CAGR of 6.2%. The reason for such growth would be the increasing prevalence of birth disorders and chronic diseases that are boosting the demand for ultrasound systems globally.

Furthermore, the domain, on the basis of application, is categorized into cardiology, oncology, gastroenterology, urology and nephrology, obstetrics and gynecology, and others. Out of these, oncology is estimated to contribute the most significant share to the interventional radiology market in the forecast period. The oncology segment is expected to generate $5.1 billion revenue for the market in 2018 and $7.3 billion by 2024. Across the globe, the increasing prevalence of cancer has boosted this segment. Furthermore, the market for gastroenterology is also expected to experience significant growth, progressing at a CAGR of 5.9% during the analysis period.

On a global ground, North America is leading the interventional radiology market in 2018 with nearly 36.0% revenue share, and it is forecasted to contribute $9.3 billion revenue by 2024. The key factors driving the growth of the domain in the region are increasing healthcare expenditure and advanced healthcare facilities. During the analysis period, the market is predicted to grow the fastest in APAC, witnessing a CAGR of 7.9%, due to the increasing prevalence of chronic diseases, improving healthcare infrastructure, and rising geriatric population and healthcare expenditure.

Moreover, developing countries, such as China and India, are increasing their healthcare expenditure to improve the healthcare infrastructure, which is impelling companies to invest in the region by creating notable revenue generation opportunities. According to the World Bank, China's healthcare expenditure in 2005 was 4.3% of its GDP, which increased to 5.3% in 10 years.

Across the globe, the interventional radiology market is registering growth owing to a substantial number of new equipment being introduced by prominent players. For instance, Canon Medical Systems Corporation, within its Vitrea platform, launched the illumination rendering technology in January 2019. This will enable real-time interaction with photorealistic images, allowing physicians to visualize patient's anatomy in all dimensions. That same year, Canon also launched the Aquilian Start CT system in Dubai.

Key Topics Covered

Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Product
1.3.2 Market Segmentation by Procedure
1.3.3 Market Segmentation by Application
1.3.4 Market Segmentation by End User
1.3.5 Market Segmentation by Geography
1.3.6 Analysis Period
1.3.7 Market Data Reporting Unit
1.3.7.1 Value
1.4 Key Stakeholders

Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Regulatory Framework Analysis
4.1 U.S.
4.2 Canada
4.3 Europe
4.4 Australia and New Zealand
4.5 Japan
4.6 China

Chapter 5. Pricing Analysis
5.1 MRI Systems
5.2 CT Scanners
5.3 Ultrasound Systems
5.4 PET/CT Scanner
5.5 Digital Cath Lab for Interventional Radiology
5.6 Fluoroscopy Systems

Chapter 6. Introduction
6.1 Definition of Market Segments
6.1.1 By Product
6.1.1.1 MRI systems
6.1.1.2 CT systems
6.1.1.3 Ultrasound systems
6.1.1.4 Angiography systems
6.1.1.5 Others
6.1.2 By Procedure
6.1.2.1 Angioplasty
6.1.2.2 Biopsy and drainage
6.1.2.3 Embolization
6.1.2.4 Catheter-directed thrombolysis
6.1.2.5 Vertebroplasty
6.1.2.6 Nephrostomy
6.1.2.7 Others
6.1.3 By Application
6.1.3.1 Cardiology
6.1.3.2 Urology and nephrology
6.1.3.3 Oncology
6.1.3.4 Gastroenterology
6.1.3.5 Obstetrics and gynecology
6.1.3.6 Others
6.1.4 By End User
6.1.4.1 Hospitals
6.1.4.2 ASCs
6.2 Market Dynamics
6.2.1 Trends
6.2.1.1 Increase in the number of product approvals and launches
6.2.2 Drivers
6.2.2.1 Technological advancements in interventional radiology systems
6.2.2.2 Increasing reimbursement rate for interventional procedures
6.2.2.3 Increasing prevalence of chronic diseases
6.2.2.4 Rise in the preference of interventional procedures
6.2.2.5 Surging aging population
6.2.2.6 Impact analysis of drivers on market forecast
6.2.3 Restraints
6.2.3.1 High cost of interventional radiology systems
6.2.3.2 Diminishing helium reserves
6.2.3.3 Dearth of skilled radiologists
6.2.3.4 Impact analysis of restraints on market forecast
6.2.4 Opportunities
6.2.4.1 Scope of healthcare in rural areas
6.3 Porter's Five Forces Analysis

Chapter 7. Global Market Size and Forecast
7.1 By Product
7.2 By Procedure
7.3 By Application
7.4 By End User
7.5 By Region

Chapter 8. North America Market Size and Forecast

Chapter 9. Europe Market Size and Forecast

Chapter 10. APAC Market Size and Forecast

Chapter 11. LATAM Market Size and Forecast

Chapter 12. MEA Market Size and Forecast

Chapter 13. Competitive Landscape

13.1 Company Benchmarking Based on Offerings
13.2 Global Strategic Developments of Key Players
13.2.1 Product Launches
13.2.2 Others

Chapter 14. Company Profiles
14.1 Samsung Electronics Co. Ltd.
14.1.1 Business Overview
14.1.2 Product and Service Offerings
14.1.3 Key Financial Summary
14.1.4 SWOT Analysis
14.2 Carestream Health Inc.
14.3 Shimadzu Corporation
14.4 Hologic Inc.
14.5 General Electric Company
14.6 Koninklijke Philips N.V.
14.7 Siemens AG
14.8 Esaote S.p.A.
14.9 Hitachi Ltd.
14.10 Canon Medical Systems Corporation

For more information about this report visit https://www.researchandmarkets.com/research/mltxnv/the_global_market?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

                    CONTACT: ResearchAndMarkets.com
                             Laura Wood, Senior Press Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                    Related Topics: Medical Imaging
                    

22157.jpg

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release